Study of TAVO103A in Healthy Volunteers

NCT05313152 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: TAVO103A
OTHER: Placebo

Sponsor

Tavotek Biotherapeutics